Table 2

Univariate and multivariate analysis and inverse probability weighting on the predictor for MACE after PCI

Univariate analysisMultivariate analysisInverse probability weighting
HR95% CIP valueHR95% CIP valueHR95% CIP value
Age1.021.01–1.040.0011.000.99–1.020.558
Male0.760.54–1.070.117
BMI0.970.92–1.020.263
Hypertension1.080.74–1.600.680
Dyslipidaemia0.610.44–0.840.0030.830.57–1.200.319
Diabetes mellitus1.210.86–1.700.274
Chronic kidney disease2.681.89–3.79<0.0011.611.07–2.410.022
LVEF4.533.18–6.47<0.0012.601.77–3.81<0.001
Killip classification2.141.89–2.43<0.0011.751.50–2.04<0.001
STEMI0.810.56–1.190.286
Prior stroke1.410.86–2.300.176
GTN use
before PCI
1.461.05–2.040.0261.571.09–2.280.0161.511.04–2.190.028
  • Bold values indicate statistical significance at the p <0.05 level.

  • Age=1-year increase; BMI categories=18.5−26, ≤18.5 or > 26; chronic kidney disease=eGFR≥60 mL/min per 1.73 m2, eGFR<60 mL/min per 1.73 m2; Killip classification=1, 2, 3, 4; LVEF≥50%, <50%.

  • BMI, body mass index; eGFR, estimated glomerular filtration rate; GTN, nitroglycerin; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular events; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.